Angola plans to build a pharmaceutical production complex by 2026 in the Special Economic Zone, capable of producing millions of tablets, vials, and medical gases. Managed by Vitaflor and funded by the Angolan Sovereign Fund, the project is expected to be completed within 18 months and will add to the existing 89 businesses in the ZEE.
Angola is set to establish a pharmaceutical production complex by 2026, located in the Special Economic Zone (ZEE) in Icolo and Bengo province. The facility will have the capacity to produce 1.7 million tablets and capsules annually, alongside 50 million vials of injectable medicines. Managed by Vitaflor company, the complex will also manufacture 35 million bags of serum and 13,000 kilograms of medical gases per day, as reported by the Jornal de Angola.
Currently in the early stages, the project is financed by the Angolan Sovereign Fund (FSA), with the first stone recently laid. The parties involved anticipate completion within the next 18 months. The Special Economic Zone already hosts over 60 active business projects, predominantly in the food and pharmaceutical sectors.
According to Manuel Pedro, the president of the board of directors of the ZEE, the country expects to see several industries operational soon, building upon the 89 existing businesses across various branches within the area.
In summary, Angola’s initiative to develop a pharmaceutical production complex by 2026 signifies a major advancement in local manufacturing capacity, particularly in healthcare. The combination of government support through the Sovereign Fund and the collaboration with Vitaflor underscores a strategic shift towards self-sufficiency in medicine production, enhancing the overall healthcare landscape in the nation.
Original Source: www.plenglish.com
